Precision Health Clinical Trials
Clinical Trial Multi-analyte Blood Test
Condition: Liver Cirrhosis
Intervention: Diagnostic Test: Multi-analyte blood Test
Sponsor: Helio Genomics
Recruiting
Intervention: Diagnostic Test: Multi-analyte blood Test
Sponsor: Helio Genomics
Recruiting
For more information, visit the Study URL.
Multi-analyte Blood Test Clinical Trial
Conditions: Liver Cirrhosis; Liver Cancer; HCC; Hepatocellular Carcinoma
Intervention: Diagnostic Test: Multi-analyte Blood Test
Sponsor: Helio Genomics
Recruiting
Intervention: Diagnostic Test: Multi-analyte Blood Test
Sponsor: Helio Genomics
Recruiting
For more information, visit the Study URL.
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Conditions: Cancer; Liver Cirrhosis; Chronic Hepatitis; Hepatitis B; Hepatitis C; Diabetes; COPD
Intervention: Diagnostic Test: Multi-analyte Blood Test
Sponsor: Helio Genomics
Recruiting
Intervention: Diagnostic Test: Multi-analyte Blood Test
Sponsor: Helio Genomics
Recruiting
For more information, visit the Study URL.
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
Conditions: Whole Genome Sequencing; Myelodysplastic Syndromes
Intervention: Device: ChromoSeq
Sponsor: Washington University School of Medicine
Recruiting
Intervention: Device: ChromoSeq
Sponsor: Washington University School of Medicine
Recruiting
For more information, visit the Study URL.
Assessment the Cancer Risk of Indeterminate Thyroid Nodules Through Integration of Clinical, Ultrasonographic and Multiomic Features
Conditions: Thyroid Nodule; Thyroid Cancer
Intervention: Diagnostic Test: Multiomic analyses of blood and surgical specimens
Sponsors: University of Cagliari; Prof. Pietro Giorgio Calò; Dott. Gian Luigi Canu
Not yet recruiting
Intervention: Diagnostic Test: Multiomic analyses of blood and surgical specimens
Sponsors: University of Cagliari; Prof. Pietro Giorgio Calò; Dott. Gian Luigi Canu
Not yet recruiting
For more information, visit the Study URL.
Pneumococcal Carriage and Serotype Distribution in Children With Otitis Media in Malaysia.
Conditions: Streptococcus Pneumonia; Otitis Media
Intervention:
Sponsors: International Medical University; International Islamic University Malaysia; Universiti Putra Malaysia; University of Southampton; Merck Sharp & Dohme LLC; Hospital Serdang
Not yet recruiting
Intervention:
Sponsors: International Medical University; International Islamic University Malaysia; Universiti Putra Malaysia; University of Southampton; Merck Sharp & Dohme LLC; Hospital Serdang
Not yet recruiting
For more information, visit the Study URL.
Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer
Condition: HER2+ Breast Cancer
Interventions: Drug: Trastuzumab; Drug: Pertuzumab; Drug: Nab paclitaxel; Drug: Pyrotinib; Drug: Capecitabine; Drug: T-DM1; Drug: Everolimus; Drug: CDK4/6 inhibitor; Drug: AI; Drug: Anti-PD-1 monoclonal antibody
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Recruiting
Interventions: Drug: Trastuzumab; Drug: Pertuzumab; Drug: Nab paclitaxel; Drug: Pyrotinib; Drug: Capecitabine; Drug: T-DM1; Drug: Everolimus; Drug: CDK4/6 inhibitor; Drug: AI; Drug: Anti-PD-1 monoclonal antibody
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Recruiting
For more information, visit the Study URL.
The Analysis of Gene Variants Related to POCD in Elderly Patients
Condition: Cognitive Dysfunction
Intervention: Procedure: Urologic Surgery
Sponsor: Istanbul University
Not yet recruiting
Intervention: Procedure: Urologic Surgery
Sponsor: Istanbul University
Not yet recruiting
For more information, visit the Study URL.
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Minimal Residual Disease Detected by Liquid Biopsy
Conditions: Gastrointestinal Stromal Tumors; Minimal Residual Disease
Intervention: Diagnostic Test: liquid biopsy
Sponsor: Peking University People's Hospital
Recruiting
Intervention: Diagnostic Test: liquid biopsy
Sponsor: Peking University People's Hospital
Recruiting
For more information, visit the Study URL.
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
Conditions: Breast Cancer; Colorectal Cancer; Pancreas Cancer; Kidney Cancer; Prostate Cancer; Ovary Cancer; Head and Neck Cancer; Leukemia; Lymphoma; Lung Cancer; Melanoma; Solid Tumor
Intervention:
Sponsors: University Health Network, Toronto; Princess Margaret Hospital, Canada; Ontario Institute for Cancer Research; Terry Fox Research Institute
Recruiting
Intervention:
Sponsors: University Health Network, Toronto; Princess Margaret Hospital, Canada; Ontario Institute for Cancer Research; Terry Fox Research Institute
Recruiting
For more information, visit the Study URL.